SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011390
Filing Date
2021-08-12
Accepted
2021-08-12 10:05:57
Documents
88
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20210630x10q.htm   iXBRL 10-Q 2407920
2 EX-31.1 ipsc-20210630xex31d1.htm EX-31.1 11878
3 EX-31.2 ipsc-20210630xex31d2.htm EX-31.2 11720
4 EX-32.1 ipsc-20210630xex32d1.htm EX-32.1 6209
5 EX-32.2 ipsc-20210630xex32d2.htm EX-32.2 6203
  Complete submission text file 0001558370-21-011390.txt   8722446

Data Files

Seq Description Document Type Size
6 EX-101.SCH ipsc-20210630.xsd EX-101.SCH 64499
7 EX-101.CAL ipsc-20210630_cal.xml EX-101.CAL 71995
8 EX-101.DEF ipsc-20210630_def.xml EX-101.DEF 226537
9 EX-101.LAB ipsc-20210630_lab.xml EX-101.LAB 551388
10 EX-101.PRE ipsc-20210630_pre.xml EX-101.PRE 418111
11 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20210630x10q_htm.xml XML 1405499
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 211165796
SIC: 2836 Biological Products, (No Diagnostic Substances)